missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
Vonoprazan Fumarate, MedChemExpress
Beskrivning
Vonoprazan Fumarate (TAK-438), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan Fumarate inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan Fumarate is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease.
Specifikationer
Specifikationer
| Kemiskt namn eller material | Vonoprazan Fumarate |
| CAS | 881681-01-2 |
| Färg | White |
| Anteckningar om renhetsgrad | Research |
| Molekylformel | C21H20FN3O6S |
| Kvantitet | 100 mg |
| Synonym | TAK-438 |
| Löslighetsinformation | DMSO : 50 mg/mL (108.35 mM; Need ultrasonic) |
| LEDER | O=C(O)/C=C/C(O)=O.O=S(N1C=C(CNC)C=C1C2=CC=CC=C2F)(C3=CC=CN=C3)=O.[(E)] |
| Molekylvikt (g/mol) | 461.46 |
| Visa mer |
Research purposes only
Produkttitel
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?